February 2022 - Page 2 of 2 - CanadianCannabisWire

TuesdayFeb 08, 2022 12:49 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Summarizes 2021 Milestones, Outlines 2022 Plans and Expectations, in Annual Letter to Shareholders

In 2021, Lexaria conducted several main studies evaluating DehydraTECH-processed CBD and nicotine The company has big plans for 2022, a year it expects to undertake three ground-breaking studies Lexaria hopes these three major studies will generate sufficient data to support either regulated IND-type applications or to stimulate corporate partnerships The company is eying larger national and international applications for DehydraTECH with the aim of generating revenue through licensing fees and royalties For Lexaria Bioscience (NASDAQ: LEXX), a drug delivery company whose patented DehydraTECH(TM) technology has proven effective in improving bioavailability, speed of onset, and efficiency of orally-delivered fat-soluble active molecules…

MondayFeb 07, 2022 12:21 pm

Flora Growth Corp. (NASDAQ: FLGC) Closes January’s Series of Hires, Appointing Joël Reyes as SVP of Global Operations

Joël Reyes’ appointment marks the third appointment in the first month of the 2022 calendar year Mr. Reyes will be responsible for implementing operational excellence across the entire organization, starting with its Columbian activities His appointment comes just in time, following the implementation of the new Colombian law allowing for the export of up to 7,900 kilograms of high-THC cannabis dried flower Flora Growth (NASDAQ: FLGC) embarked on an aggressive hiring campaign to kick off the 2022 calendar year, starting with the appointment of Derek Pedro as an advisor to its Cosechemos cultivation facility (https://cnw.fm/HRIoW). This was then followed by…

FridayFeb 04, 2022 10:17 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Journey: From Runners’ Knee to Canada’s 101 Top F&B Start-up List

BevCanna Enterprises Inc is a diversified health & wellness beverage and natural products companies which deals in the manufacture and distribution of both, in-house brands, and white-label clients The company currently boasts over 3,000 points of distribution and online through which it retails the company’s market-leading TRACE brand, its Pure Therapy natural health products as well as its various, cannabis infused beverages. BevCanna’s strong execution recently saw it report 3Q2021 revenues of $1.1 million, representing a rise of over 1,000% relative to a year ago BevCanna Enterprises separately announced that it has been named as one of the 101 Top Food…

ThursdayFeb 03, 2022 10:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition

Cannabicitran is the first of four new rare cannabinoids InMed is planning to launch in the first half of the year to meet growing inbound demand The launch demonstrates InMed’s ability to produce rare cannabinoids at scale, something only very few companies have achieved BayMedica acquisition, other key achievements in 2021, are positioning the company as a leading supplier of rare cannabinoids in the health and wellness sector A leader in the research, development, manufacturing and commercialization of rare cannabinoids, InMed Pharmaceuticals (NASDAQ: INM) has begun the new year from a more prominent position in the market, following key acquisitions…

WednesdayFeb 02, 2022 2:03 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Sets to Benefit Amid a Rapidly Growing Market

BevCanna is company developing diversified portfolio of health and wellness products for both in-house brands and white-labeled clients Company deploys a traditional retail and direct-to-consumer e-commerce model to offer products throughout North America Company actively explores opportunities within infused beverages market as CBD-infused beverages gain popularity; global market expected to reach US$2 billion by 2026 BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a Canada-based diversified health and wellness beverage and natural products company developing and manufacturing a diverse portfolio of alkaline, plant-based, and cannabinoid beverages and supplements for in-house brands and white-label clients alike. Founded in 2017, BevCanna…

TuesdayFeb 01, 2022 2:18 pm

The Alternative Products Expo To Offer Important Networking Opportunities

The Alternative Products Expo arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top cities of America, ZJ Events is all set to host an exciting new event in Fort Lauderdale, The Alternative Products Expo. The alternative product category includes herbal products, mood enhancers, cannabis derivatives, vape products, energy…

TuesdayFeb 01, 2022 1:29 pm

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoids As a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly desired position to undertake large-scale production of other rare cannabinoids, with applications as wide as the current CBD market The company plans to launch new rare cannabinoid products in the first half of…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977

Month: February 2022

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Summarizes 2021 Milestones, Outlines 2022 Plans and Expectations, in Annual Letter to Shareholders

Flora Growth Corp. (NASDAQ: FLGC) Closes January’s Series of Hires, Appointing Joël Reyes as SVP of Global Operations

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Journey: From Runners’ Knee to Canada’s 101 Top F&B Start-up List

InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Sets to Benefit Amid a Rapidly Growing Market

The Alternative Products Expo To Offer Important Networking Opportunities

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

CanadianCannabisWire Currently Accepts

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 905.674.5977

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Summarizes 2021 Milestones, Outlines 2022 Plans and Expectations, in Annual Letter to Shareholders

Flora Growth Corp. (NASDAQ: FLGC) Closes January’s Series of Hires, Appointing Joël Reyes as SVP of Global Operations

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Journey: From Runners’ Knee to Canada’s 101 Top F&B Start-up List

InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Sets to Benefit Amid a Rapidly Growing Market

The Alternative Products Expo To Offer Important Networking Opportunities

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

CanadianCannabisWire Currently Accepts

Company Search

Site Search